# Arpesh Mehta

> Arpesh Mehta is a Series A investor at DSM Venturing (New York) backing Fuel and Energy. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [DSM Venturing](https://shizune.co/investors/profile/dsm-venturing)
- Location: New York, United States
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/arpeshmehta/

Arpesh Mehta is a Series A investor at DSM Venturing in New York focused on Fuel and Energy. Mr. Arpesh Mehta served as a Senior Research Associate of Ceregene. Mr. Mehta is playing an integral role in the development and IND submission for an Alzheimer’s disease therapeutic, and worked on the preclinical development of a gene therapy product in clinical trials. Mr. Mehta worked on numerous investments in the clean technology andbiotechnology sectors, being involved with all stages of the investment process from evaluating investment prospects to board governance. Mr. Mehta's cleantech investment involvement includes Virent, EcoSynthetix, Aspectrics (acquired by Guided Wave), BrightSource Energy, and Sindicatum Renewable Resources. Prior to Black River, Mr. Mehta held various R&D and marketing positions in the biotech industry. He worked as a staff researcher at the Geffen School of Medicine at UCLA, where he published numerous papers on the characterization of potential drug targets and has presented his research at international conferences. In addition, Mr. Mehta was a summer marketing intern at Genentech. His experience spans multiple functions within life science. He serves as a Director at Cargill Ventures and Black River Asset Management. He serves as a Director of Prometheus Energy Company. He serves as Observer of Alvine Pharmaceuticals, Inc. He received an M.B.A. from the Kellogg School at Northwestern University, an M.S. in Biomedical Engineering from UCLA, and a B.A. in Biology from the University of Pennsylvania.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Fuel | 1 | 33% |
| Energy | 1 | 33% |
| Hospital | 1 | 33% |
| Health Care | 1 | 33% |
| Oil and Gas | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 67% |
| Funding Round | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| Canada | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Enhanced Medical Nutrition | Enhanced Medical Nutrition builds clinical nutrition products to help patients prepare better and recover faster from surgery. | $5M | Series A | Jan 14, 2025 |  |
| Alvine Pharmaceuticals | Alvine Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing therapeutics for autoimmune/gastrointestinal diseases. Alvine's lead product candidate, ALV003, is a combination protease engineered to digest gluten. It is being developed to treat patients with celiac disease. | $21.5M | Series A | Sep 11, 2006 |  |
| Prometheus Energy | Prometheus Energy works with partners across a range of fuel-intensive sectors to provide them with lower-cost, lower-carbon, integrated energy solutions in way of natural gas (in liquid form) from waste and conventional sources. Prometheus is privately owned by Shell Technology Venture Fund and Black River Asset Management Fund (wholly owned byCargill). | $20M |  |  |  |

3 of 3 investments shown.

## Co-investors
- [Ajinomoto](https://shizune.co/investors/profile/ajinomoto) — VC Fund, 1 deal together
- [Elder Ventures](https://shizune.co/investors/profile/elder-ventures) — VC Fund, 1 deal together
- [Panorama Capital](https://shizune.co/investors/profile/panorama-capital) — VC Fund, 1 deal together
- [PeakBridge](https://shizune.co/investors/profile/peakbridge) — VC Fund, 1 deal together
- [Prospect Venture Partners](https://shizune.co/investors/profile/prospect-venture-partners) — VC Fund, 1 deal together
- [Sofinnova Investments](https://shizune.co/investors/profile/sofinnova-ventures) — VC Fund, 1 deal together

## About DSM Venturing

VC Fund · Heerlen, The Netherlands

Founded in 2002, DSM Venturing is the corporate venture capital arm of Royal DSM, based in Heerlen, Netherlands. The firm invests in companies developing innovative products and services in sectors of life sciences (animal and human health & nutrition) and biomedical.

5 contacts available at DSM Venturing.

| Name | Title | Profile |
| --- | --- | --- |
| Akshat Kshetrapal | Investment Director | https://shizune.co/investors/profile/akshat-kshetrapal-bfc7 |
| Arpesh Mehta | Investment Director | https://shizune.co/investors/profile/arpesh-mehta |
| Greg McParland | Investment Director | https://shizune.co/investors/profile/greg-mcparland |
| Iulian Baxan | Analyst | https://shizune.co/investors/profile/iulian-baxan |
| Luda Kopeikina | Investment Director | https://shizune.co/investors/profile/luda-kopeikina |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Arpesh Mehta invest in?

Arpesh Mehta invests primarily in Fuel, Energy and Hospital startups, most often at Series A and Funding Round stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Arpesh Mehta last invest?

The most recent investment recorded for Arpesh Mehta closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co